ASTRO Presentations Highlight Role of TomoTherapy® in Combined Modality Approach to Treating Cancer

MADISON, Wis – TomoTherapy Incorporated (NASDAQ: TOMO) announced today that several clinical presentations at the American Society for Radiation Oncology’s 51st ASTRO Annual Meeting – November 1-5, 2009 in Chicago – will showcase the use of the TomoTherapy® radiation therapy platform as a vital component in the combined modality approach to treating cancer. Additionally, other presentations will explore how TomoTherapy technology is being employed to treat a growing array of challenging indications.

The TomoTherapy Hi·Art® treatment system is a CT scanner-based device that integrates image guidance and helical radiation therapy delivery for increased accuracy and enhanced tumor targeting. There are more than 250 Hi·Art systems in use around the world. More than 45 presentations will be made at ASTRO, detailing how TomoTherapy technology is helping cancer centers around the world improve cancer care through daily imaging and more precise delivery of radiation to targets throughout the body.

Some of the most compelling presentations focus on how the TomoTherapy Hi·Art system has been used to increase dosage to tumors while minimizing toxicity to patients. As a result, the TomoTherapy system is establishing itself as an effective radiation therapy solution for clinicians seeking to explore a combined modality approach that more effectively treats cancer by combining radiotherapy with chemotherapy and/or surgery.

surce: TomoTherapy